The Impact of the Opioid Epidemic on Children and Adolescents

Overview

Journal Clin Ther

Specialty Pharmacology

Date 2019 Jul 16

PMID 31303278

Citations 26

Authors

Erin L Winstanley

Amanda N Stover

Affiliations

Soon will be listed here.

Abstract

Although an epidemic of opioid-related overdose deaths has continued to increase in the United States for 2 decades, the impact of opioid use disorders (OUDs) on children and families receives minimal attention. The purpose of this commentary was to provide an overview of the impact of the opioid epidemic on children and adolescents, as well as to summarize challenges to improving outcomes for children. Children and adolescents who grow up in households with opioid misuse and OUDs may experience a myriad of adverse consequences, including: increased risk of mental health problems and drug use; accidental opioid poisoning; increased risk of developing a substance use disorder; and family dissolution that results from parents' incarceration, foster care placement, or loss of parent to an opioid overdose. Parental drug use may result in child neglect or deficits in parent-child attachment, and parents with an OUD may be less likely to be reunified with their children. OUD treatment is effective at reducing parental opioid use and improving child outcomes; however, stigma and cross-system collaboration may limit access to treatment and timely reunification of families. Children are the most vulnerable witnesses of the opioid epidemic, and further research is urgently needed to expand prevention interventions.

Citing Articles

Orphanhood and caregiver death among children in the United States by all-cause mortality, 2000-2021.

Villaveces A, Chen Y, Tucker S, Blenkinsop A, Cluver L, Sherr L Nat Med. 2025; 31(2):672-683.

PMID: 39794613 PMC: 11835524. DOI: 10.1038/s41591-024-03343-6.

Impact of exposure to opioids in pregnancy on offspring developmental outcomes in the preschool years: an umbrella review.

Robertson S, Hughes T, Boardman J, McFadden A, Whittaker A, Marryat L BMJ Paediatr Open. 2025; 9(1.

PMID: 39788873 PMC: 11749434. DOI: 10.1136/bmjpo-2024-003058.

Opioid use, prescribing patterns, and disposal after surgical procedures.

Hanson L, Hummel P, Kokko-Ludemann J, Lee K, Polgreen L Explor Res Clin Soc Pharm. 2024; 15:100476.

PMID: 39712865 PMC: 11662278. DOI: 10.1016/j.rcsop.2024.100476.

Prolonged magnesium sulfate infusion as adjuvant analgesia in postoperative transplant patients in the pediatric ICU: Preliminary results of a feasibility study.

Resch J, Graf S, Ghalban R, Chinnakotla S, Fischer G Paediatr Neonatal Pain. 2024; 6(4):203-212.

PMID: 39677031 PMC: 11645970. DOI: 10.1002/pne2.12131.

Nurses' Experiences and Perspectives Caring for People With Substance Use Disorder and Their Families: A Qualitative Descriptive Study.

Kitt-Lewis E, Adam M Int J Ment Health Nurs. 2024; 34(1):e13435.

PMID: 39344349 PMC: 11751758. DOI: 10.1111/inm.13435.

References

Solis J, Shadur J, Burns A, Hussong A . Understanding the diverse needs of children whose parents abuse substances. Curr Drug Abuse Rev. 2012; 5(2):135-47. PMC: 3676900. DOI: 10.2174/1874473711205020135. View

Hawkins J, Catalano R, MILLER J . Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull. 1992; 112(1):64-105. DOI: 10.1037/0033-2909.112.1.64. View

Comiskey C . A 3 year national longitudinal study comparing drug treatment outcomes for opioid users with and without children in their custodial care at intake. J Subst Abuse Treat. 2012; 44(1):90-6. DOI: 10.1016/j.jsat.2012.04.002. View

Wolfe E, Guydish J, Santos A, Delucchi K, Gleghorn A . Drug treatment utilization before, during and after pregnancy. J Subst Use. 2012; 12(1):27-38. PMC: 3377323. DOI: 10.1080/14659890600823826. View

Feder K, Letourneau E, Brook J . Children in the Opioid Epidemic: Addressing the Next Generation's Public Health Crisis. Pediatrics. 2018; 143(1). PMC: 6317647. DOI: 10.1542/peds.2018-1656. View

Chatterjee A, Larochelle M, Xuan Z, Wang N, Bernson D, Silverstein M . Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014. Drug Alcohol Depend. 2018; 194:28-31. PMC: 6312455. DOI: 10.1016/j.drugalcdep.2018.09.020. View

Jones C, Campopiano M, Baldwin G, McCance-Katz E . National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment. Am J Public Health. 2015; 105(8):e55-63. PMC: 4504312. DOI: 10.2105/AJPH.2015.302664. View

Huhn A, Berry M, Dunn K . Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder. Am J Addict. 2019; 28(4):246-261. PMC: 6591072. DOI: 10.1111/ajad.12921. View

Andrilla C, Coulthard C, Larson E . Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder. Ann Fam Med. 2017; 15(4):359-362. PMC: 5505456. DOI: 10.1370/afm.2099. View

10.

Coall D, Hilbrand S, Hertwig R . Predictors of grandparental investment decisions in contemporary Europe: biological relatedness and beyond. PLoS One. 2014; 9(1):e84082. PMC: 3885520. DOI: 10.1371/journal.pone.0084082. View

11.

Barnard M, McKeganey N . The impact of parental problem drug use on children: what is the problem and what can be done to help?. Addiction. 2004; 99(5):552-9. DOI: 10.1111/j.1360-0443.2003.00664.x. View

12.

Famularo R, Kinscherff R, Fenton T . Parental substance abuse and the nature of child maltreatment. Child Abuse Negl. 1992; 16(4):475-83. DOI: 10.1016/0145-2134(92)90064-x. View

13.

Kapusta N, Tran U, Rockett I, De Leo D, Naylor C, Niederkrotenthaler T . Declining autopsy rates and suicide misclassification: a cross-national analysis of 35 countries. Arch Gen Psychiatry. 2011; 68(10):1050-7. DOI: 10.1001/archgenpsychiatry.2011.66. View

14.

Wu L, Blazer D, Li T, Woody G . Treatment use and barriers among adolescents with prescription opioid use disorders. Addict Behav. 2011; 36(12):1233-9. PMC: 3179790. DOI: 10.1016/j.addbeh.2011.07.033. View

15.

Kennedy-Hendricks A, Levin J, Stone E, McGinty E, Gollust S, Barry C . News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic. Health Aff (Millwood). 2019; 38(4):643-651. DOI: 10.1377/hlthaff.2018.05075. View

16.

Mitchell K, Nolte K, Turner H, Hamby S, Jones L . Exposure to Medication Overdose as an Adversity in Childhood. J Pediatr Nurs. 2017; 38:127-132. DOI: 10.1016/j.pedn.2017.09.006. View

17.

Stein M, Conti M, Kenney S, Anderson B, Flori J, Risi M . Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder. Drug Alcohol Depend. 2017; 179:325-329. PMC: 5599365. DOI: 10.1016/j.drugalcdep.2017.07.007. View

18.

LeTendre M, Reed M . The Effect of Adverse Childhood Experience on Clinical Diagnosis of a Substance Use Disorder: Results of a Nationally Representative Study. Subst Use Misuse. 2017; 52(6):689-697. PMC: 5519323. DOI: 10.1080/10826084.2016.1253746. View

19.

Volkow N, Frieden T, Hyde P, Cha S . Medication-assisted therapies--tackling the opioid-overdose epidemic. N Engl J Med. 2014; 370(22):2063-6. DOI: 10.1056/NEJMp1402780. View

20.

Conroy E, Degenhardt L, Mattick R, Nelson E . Child maltreatment as a risk factor for opioid dependence: Comparison of family characteristics and type and severity of child maltreatment with a matched control group. Child Abuse Negl. 2009; 33(6):343-52. PMC: 2729332. DOI: 10.1016/j.chiabu.2008.09.009. View